Next Article in Journal
Large Scale Shrub Biomass Estimates for Multiple Purposes
Previous Article in Journal
Exotic Species and Autochthonous Parasites: Trichostrongylus Retortaeformis in Eastern Cottontail
Open AccessArticle

Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance

1
Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
2
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
3
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA
*
Author to whom correspondence should be addressed.
Life 2020, 10(4), 32; https://doi.org/10.3390/life10040032
Received: 26 February 2020 / Revised: 19 March 2020 / Accepted: 20 March 2020 / Published: 26 March 2020
(This article belongs to the Section Medical Research)
A precision health initiative was implemented across a multi-hospital health system, wherein a panel of genetic variants was tested and utilized in the clinical care of chronic kidney disease (CKD) patients. Pharmacogenomic predictors of antihypertensive response and genomic predictors of CKD were provided to clinicians caring for nephrology patients. To assess clinician knowledge, attitudes, and willingness to act on genetic testing results, a Likert-scale survey was sent to and self-administered by these nephrology providers (N = 76). Most respondents agreed that utilizing pharmacogenomic-guided antihypertensive prescribing is valuable (4.0 ± 0.7 on a scale of 1 to 5, where 5 indicates strong agreement). However, the respondents also expressed reluctance to use genetic testing for CKD risk stratification due to a perceived lack of supporting evidence (3.2 ± 0.9). Exploratory sub-group analyses associated this reluctance with negative responses to both knowledge and attitude discipline questions, thus suggesting reduced exposure to and comfort with genetic information. Given the evolving nature of genomic implementation in clinical care, further education is warranted to help overcome these perception barriers. View Full-Text
Keywords: chronic kidney disease (CKD), hypertension (HTN), genetic testing; pharmacogenomics; APOL1 chronic kidney disease (CKD), hypertension (HTN), genetic testing; pharmacogenomics; APOL1
Show Figures

Figure 1

MDPI and ACS Style

Spiech, K.M.; Tripathy, P.R.; Woodcock, A.M.; Sheth, N.A.; Collins, K.S.; Kannegolla, K.; Sinha, A.D.; Sharfuddin, A.A.; Pratt, V.M.; Khalid, M.; Hains, D.S.; Moe, S.M.; Skaar, T.C.; Moorthi, R.N.; Eadon, M.T. Implementation of a Renal Precision Medicine Program: Clinician Attitudes and Acceptance. Life 2020, 10, 32.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop